When you work in quality management, it's important to keep up with the latest in compliance and regulation requirements. Conferences can a great way to update your knowledge and expand your network at the same time. Since there are so many events throughout the year, it's also important to invest your time wisely.We spoke to a few of our customers recently to learn which events they found valuable. Here is a roundup of upcoming conferences to consider checking out:
Cardiaccs AS was founded in 2009 as a result of 8 years of research and development by the Intervention Centre at Oslo University Hospital in cooperation with Buskerud and Vestfold University College. In 2014, the company received funding from the Research Council of Norway/FORNY2020 program to commercialize their Cardisense sensor technology.
We’ve got some big news. On November 6th ZenDoc will officially become Qualio. We’re changing our name to more accurately reflect our company vision. The past two years have been incredible and now it's time to double down on our efforts to become the simplest way for businesses to manage quality & compliance. The first step on this path is a rebrand to reflect our new focus. The important thing to know for now is that when the switchover happens all links to ZenDoc will now take you to Qualio and everything will work just as it did before. That means you can expect the same great service as always, now under a new name.
This change coincides with the opening our first office in the United States. Now with locations in San Francisco, CA and Dublin, Ireland we can better serve our customers all over the world.
Robert & the team at Qualio
P.S. Have any questions about this change?
Let us know in the comments!
What if we could increase productivity and stave the capital flight by helping Life Sciences startups build their companies more efficiently? We’re going to test this hypothesis by teaching a Lean LaunchPad class for Life Sciences and Health Care (therapeutics, diagnostics, devices and digital health) this October at UCSF with a team of veteran venture capitalists.
Part 1 of this post described the issues in the drug discovery. Part 2 covered medical devices and digital health. This post describes what we’re going to do about it. And why you ought to take this class. When I wrote Four Steps to the Epiphany and the Startup Owners Manual, I believed that Life Sciences startups didn’t need Customer Discovery. Heck how hard could it be? You invent a cure for cancer and then figure out where to put the bags of money. (In fact, for oncology, with a successful clinical trial, this is the case.)
What if we could increase productivity and stave the capital flight by helping Life Sciences startups build their companies more efficiently?